Convenio Anual de Medicamentos Orales y Subcutáneos
Se requiere efectuar CONVENIO ANUAL DE MEDICAMENTOS ORALES Y SUBCUTÁNEOS solicitados por Farmacia Central del HTC.
20 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2157-1941-SE17 | 22-08-2017 | Laboratorios Andromaco S.A. | $34.391 |
| 2157-1925-SE17 | 21-08-2017 | Opko Chile S.A. | $100.674 |
| 2157-1926-SE17 | 21-08-2017 | Laboratorios Recalcine S.A. | $204.561 |
| 2157-1729-SE17 | 26-07-2017 | Winpharm SpA | $42.840 |
| 2157-1527-SE17 | 05-07-2017 | Laboratorios Andromaco S.A. | $130.424 |
| 2157-1519-SE17 | 04-07-2017 | Pfizer Chile S.A. | $9.474.423 |
| 2157-1513-SE17 | 04-07-2017 | Laboratorios Recalcine S.A. | $307.734 |
| 2157-1512-SE17 | 04-07-2017 | Laboratorios Andromaco S.A. | $332.581 |
| 2157-1514-SE17 | 04-07-2017 | Aventis Pharma Holding Gmbh | $585.480 |
| 2157-1374-SE17 | 15-06-2017 | Opko Chile S.A. | $33.320 |
| 2157-1355-SE17 | 14-06-2017 | Pfizer Chile S.A. | $5.124.438 |
| 2157-839-SE17 | 13-06-2017 | Opko Chile S.A. | $432.327 |
| 2157-840-SE17 | 13-06-2017 | Laboratorio Sanderson S.A. | $321.300 |
| 2157-838-SE17 | 13-06-2017 | Novofarma Service S.A. | $39.484 |
| 2157-1266-SE17 | 02-06-2017 | Laboratorios Recalcine S.A. | $307.020 |
| 2157-1194-SE17 | 29-05-2017 | Laboratorios Andromaco S.A. | $195.636 |
| 2157-1154-SE17 | 23-05-2017 | Opko Chile S.A. | $24.990 |
| 2157-983-SE17 | 04-05-2017 | Pfizer Chile S.A. | $4.730.250 |
| 2157-858-SE17 | 13-04-2017 | Laboratorio Sanderson S.A. | $214.200 |
| 2157-820-SE17 | 10-04-2017 | Laboratorios Andromaco S.A. | $163.030 |
| 2157-816-SE17 | 10-04-2017 | Pfizer Chile S.A. | $4.730.250 |
| 2157-707-SE17 | 28-03-2017 | Novofarma Service S.A. | $26.323 |
| 2157-694-SE17 | 27-03-2017 | Opko Chile S.A. | $241.570 |
| 2157-545-SE17 | 09-03-2017 | Aventis Pharma Holding Gmbh | $76.112 |
| 2157-527-SE17 | 07-03-2017 | Laboratorios Recalcine S.A. | $111.503 |
| 2157-514-SE17 | 06-03-2017 | Laboratorios Andromaco S.A. | $163.030 |
| 2157-481-SE17 | 02-03-2017 | Opko Chile S.A. | $226.100 |
| 2157-478-SE17 | 01-03-2017 | Laboratorios Recalcine S.A. | $316.659 |
| 2157-2019-SE16 | 13-02-2017 | Novofarma Service S.A. | $105.291 |
| 2157-346-SE17 | 13-02-2017 | Laboratorio Sanderson S.A. | $214.200 |
| 2157-313-SE17 | 07-02-2017 | Laboratorios Recalcine S.A. | $476.952 |
| 2157-231-SE17 | 26-01-2017 | Laboratorios Recalcine S.A. | $637.602 |
| 2157-236-SE17 | 26-01-2017 | Pfizer Chile S.A. | $4.730.250 |
| 2157-235-SE17 | 26-01-2017 | Opko Chile S.A. | $212.367 |
| 2157-148-SE17 | 17-01-2017 | Laboratorios Andromaco S.A. | $163.030 |
| 2157-3016-SE16 | 30-12-2016 | Laboratorio Chile S.A. | $128.520 |
| 2157-2988-SE16 | 29-12-2016 | Pfizer Chile S.A. | $3.941.875 |
| 2157-2967-SE16 | 29-12-2016 | Winpharm SpA | $10.710 |
| 2157-2964-SE16 | 29-12-2016 | Aventis Pharma Holding Gmbh | $819.672 |
| 2157-2907-SE16 | 21-12-2016 | Opko Chile S.A. | $226.100 |
| 2157-2877-SE16 | 15-12-2016 | Laboratorios Recalcine S.A. | $407.456 |
| 2157-2025-SE16 | 15-12-2016 | Laboratorio Chile S.A. | $15.470 |
| 2157-2878-SE16 | 15-12-2016 | Pfizer Chile S.A. | $3.941.875 |
| 2157-2840-SE16 | 13-12-2016 | Laboratorios Andromaco S.A. | $163.030 |
| 2157-2687-SE16 | 21-11-2016 | Opko Chile S.A. | $208.845 |
| 2157-2693-SE16 | 21-11-2016 | Pfizer Chile S.A. | $69.615 |
| 2157-2602-SE16 | 09-11-2016 | Pfizer Chile S.A. | $3.153.500 |
| 2157-2544-SE16 | 28-10-2016 | Pfizer Chile S.A. | $69.615 |
| 2157-2543-SE16 | 28-10-2016 | Laboratorios Recalcine S.A. | $401.149 |
| 2157-2559-SE16 | 28-10-2016 | Laboratorios Andromaco S.A. | $103.530 |
| 2157-2476-SE16 | 20-10-2016 | Pfizer Chile S.A. | $394.188 |
| 2157-2412-SE16 | 13-10-2016 | Aventis Pharma Holding Gmbh | $819.672 |
| 2157-2378-SE16 | 11-10-2016 | Laboratorio Sanderson S.A. | $428.400 |
| 2157-2330-SE16 | 05-10-2016 | Opko Chile S.A. | $233.240 |
| 2157-2285-SE16 | 29-09-2016 | Laboratorios Recalcine S.A. | $770.168 |
| 2157-2230-SE16 | 23-09-2016 | Laboratorios Recalcine S.A. | $449.820 |
| 2157-2202-SE16 | 20-09-2016 | Laboratorio Sanderson S.A. | $214.200 |
| 2157-2174-SE16 | 13-09-2016 | Laboratorios Recalcine S.A. | $157.794 |
| 2157-2155-SE16 | 12-09-2016 | Winpharm SpA | $10.710 |
| 2157-2018-SE16 | 12-09-2016 | Laboratorios Andromaco S.A. | $205.870 |
| 2157-2026-SE16 | 12-09-2016 | Laboratorio Sanderson S.A. | $214.200 |
| 2157-2024-SE16 | 09-09-2016 | Pfizer Chile S.A. | $830.144 |
| 2157-2101-SE16 | 06-09-2016 | Laboratorios Recalcine S.A. | $830.739 |
| 2157-2022-SE16 | 05-09-2016 | Aventis Pharma Holding Gmbh | $819.672 |
| 2157-2020-SE16 | 30-08-2016 | Laboratorios Recalcine S.A. | $268.202 |
| 2157-2021-SE16 | 30-08-2016 | Opko Chile S.A. | $212.296 |
Fuente original:ficha mercadopublico.cl
